Seres Therapeutics
MCRB
#8981
Rank
S$0.12 B
Marketcap
$0.74
Share price
-3.90%
Change (1 day)
-24.55%
Change (1 year)

Earnings for Seres Therapeutics (MCRB)

Earnings in 2024 (TTM): -S$0.18 Billion

According to Seres Therapeutics's latest financial reports the company's current earnings are N/A. a decrease over its 2023 earnings that were of -S$0.14 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Seres Therapeutics from 2014 to 2024

Annual earnings

Year Earnings Change
2024 -S$0.18 Billion34.63%
2023 -S$0.14 Billion-59.97%
2022 -S$0.33 Billion289.57%
2021 -S$84.64 Million-27.3%
2020 -S$0.12 Billion23%
2019 -S$94.66 Million-30.11%
2018 -S$0.14 Billion9.73%
2017 -S$0.13 Billion-0.74%
2016 -S$0.13 Billion70.96%
2015 -S$72.74 Million257.11%
2014 -S$20.37 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$0.33 Billion 84.67%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$0.35 Billion 94.19%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$0.58 Billion 223.94%๐Ÿ‡บ๐Ÿ‡ธ USA